Prescription drug · NDA
Tudorza Pressair (Aclidinium bromide) NDC 70515-002
Aclidinium bromide 400 ug/1 · Powder, Metered · Respiratory (Inhalation) · Covis Pharma US, Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70515-002-01 | 70515000201 | 1 POUCH in 1 CARTON (70515-002-01) / 1 INHALER in 1 POUCH / 60 POWDER, METERED in 1 INHALERMarketed from Jul 1, 2015 | |
| 70515-002-02 | 70515000202 | 1 POUCH in 1 CARTON (70515-002-02) / 1 INHALER in 1 POUCH / 30 POWDER, METERED in 1 INHALERMarketed from Jul 1, 2015 | |
| 70515-002-03 | 70515000203 | 1 POUCH in 1 CARTON (70515-002-03) / 1 INHALER in 1 POUCH / 30 POWDER, METERED in 1 INHALERMarketed from Jul 1, 2015 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tudorza Pressair
- Generic name (nonproprietary)
- aclidinium bromide
- Active ingredients
- Aclidinium bromide — 400 ug/1
- Dosage form
- Powder, Metered
- Route
- Respiratory (Inhalation)
- Labeler
- Covis Pharma US, IncNDC labeler code 70515
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 202450
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Antagonists (Mechanism)
- Identifiers
- Product ID 70515-002_86a2e74d-bbf7-4de6-af00-3d23ee80630aSPL ID 86a2e74d-bbf7-4de6-af00-3d23ee80630aSPL set ID 6f92cceb-a63f-4470-99b6-56179d98f10fRxCUI 1303102, 1303107, 1607111, 1607112UNII UQW7UF9N91
- Pharmacologic class
- Anticholinergic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N470515000201followed by a unit qualifier and the quantityPackage 70515-0002-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). TUDORZA PRESSAIR is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). (1)
Excerpt only. Read the full label for complete information.
About NDC 70515-002
- What is NDC 70515-002?
- 70515-002 is the product NDC for Tudorza Pressair (aclidinium bromide), Aclidinium bromide 400 ug/1 powder, metered, listed with the FDA by Covis Pharma US, Inc. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tudorza Pressair (Aclidinium bromide).
- What is the active ingredient?
- Aclidinium bromide.
- Who is the labeler?
- Covis Pharma US, Inc, NDC labeler code 70515. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tudorza Pressair?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.